Should asymptomatic progression following definitive local treatment for prostate cancer be treated?

Hematology/Oncology Clinics of North America

Volumn 10, Issue 3, 1996, Pages 703-712

  Lillis, P ^a   Thompson Jr , I M ^a  

^a BROOKE ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; EARLY DIAGNOSIS; HUMAN; MALE; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; TREATMENT OUTCOME;

EID: 0030014821     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8588(05)70362-2     Document Type: Article

References (68)

1. T.E. Ahlering G. Lieskovsky D.G. Skinner Salvage surgery plus androgen deprivation for radioresistant prostatic adenocarcinoma J Urol 147 1992 900 902
2. M.S. Anscher L.R. Prosnitz Postoperative radiotherapy for patients with carcinoma of the prostate undergoing radical prostatectomy with positive surgical margins, seminal vesicle involvement and/or penetration through the capsule J Urol 138 1987 1407 1412
3. J.T. Bishoff A. Reyes I.M. Thompson Pelvic lymphadenectomy can be omitted in selected patients with prostate cancer: Development of a system of patient selection Urology 45 1995 270
4. W.J. Catalona S.W. Bigg Nerve-sparing radical prostatectomy: Evaluation of results after 250 patients J Urol 143 1990 538 544
5. W.J. Catalona Radical surgery for advanced prostate cancer and for radiation failures [editorial] J Urol 147 1992 916
6. M.D. Cosgrove F.W. George III R. Terry The effects of treatment on the local lesion of carcinoma of the prostate J Urol 169 1973 861 865
7. J.D. Cox R.W. Kline Do prostatic biopsies 12 months or more after external irradiation for adenocarcinoma Stage III, predict long-term survival? Int J Radiat Oncol Biol Phys 9 1983 299 303
8. J.D. Cox T.J. Stoffel The significance of needle biopsy after irradiation for stage C adenocarcinoma of the prostate Cancer 40 1977 156 160
9. R.S. Cox I.D. Kaplan M.A. Bagshaw Prostate-specific antigen kinetics after external beam irradiation for carcinoma of the prostate Int J Radiat Oncol Biol Phys 28 1994 23 31
10. E.D. Crawford M.A. Eisenberger D.G. McLeod A controlled trial of leuprolide with and without flutamide in prostatic carcinoma N Engl J Med 321 1989 419 424
11. J.M. Crook G.A. Perry S. Robertson Routine prostate biopsies following radiotherapy for prostate cancer: Results for 226 patients Urology 45 1995 624 632
12. 125 Idoine reimplantation and pelvic lymphadenectomy for prostatic cancer with special reference to patients who had failed external beam therapy as their initial mode of therapy J Urol 126 1981 620 622
13. G. Dohm S. Degro Therapy of prostatic cancer and histopathologic follow-up Prostate 3 1982 531 542
14. T.C. Dugan W.P. Shipley R.H. Young Biopsy after external beam radiation therapy for adenocarcinoma of the prostate: Correlation with original histologic grade and current prostate specific antigen levels J Urol 146 1991 1313
15. A. Eisbruch C.A. Perez E.H. Roessler Adjuvant irradiation after for carcinoma of the prostate with positive surgical margins Cancer 73 1994 384 388
16. R.P. Gibbons B.S. Cole R.G. Richardson Adjuvant radiotherapy following radical prostatectomy: Results and complications J Urol 135 1986 65 68
17. 125 Idoine prostate implants for recurrent carcinomas after external beam irradiation: Preliminary results Cancer 45 1980 2727 2724
18. S.L. Goldenberg N. Bruchovsky M.E. Gleave Intermittent androgen suppression in the treatment of prostate cancer: A preliminary report Urology 45 1995 839 845
19. G. Hanks The prostate J.D. Cox Moss' Radiation Oncology: Rationale, Technique, Results 1994 Mosby St. Louis
20. G.E. Hanks A. D'Amico B.E. Epstein Prostatic-specific antigen doubling times in patients with prostate cancer: A potentially useful reflection of tumor doubling time Int J Radiat Oncol Biol Phys 27 1993 125 127
21. G.E. Hanks K.L. Martz J.M. Krall Analysis of independent variables affecting survival after recurrence of prostate cancer Int J Radiat Oncol Biol Phys 16 1989 1431 1435
22. A.L. Hanlon G.E. Hanks W.R. Lee PSA doubling time is an independent predictor for outcome of prostate cancer treated by external beam radiation [abstract] Int J Radiat Oncol Biol Phys 32 suppl 1 1995 1018
23. G.M. Jacobson J.A. Smith J.R. Stewart Postoperative radiation for pathologic stage C prostate cancer Int J Radial Oncol Biol Phys 13 1987 1021 1024
24. A.R. Kagan J. Gordon J.F. Cooper A clinical appraisal of post-irradiation biopsy in prostatic cancer Cancer 39 1977 637 641
25. I.D. Kaplan M.A. Bagshaw Serum prostate specific antigen after post-prostatectomy radiotherapy Urology 39 1992 401 406
26. I.D. Kaplan B.R. Prestige R.S. Cox Prostate specific antigen after irradiation for prostatic carcinoma J Urol 144 1990 1172 1176
27. I.D. Kaplan R.S. Cox M.A. Bagshaw Prostate specific antigen after external beam for prostatic cancer: Followup J Urol 149 1993 519 522
28. I.D. Kaplan R.S. Cox M.A. Bagshaw A model of prostatic carcinoma tumor kinetics based on prostate specific antigen levels after radiation therapy Cancer 68 1991 400 405
29. I.D. Kaplan B.R. Prestige M.A. Bagshaw The importance of local control in the treatment of prostatic cancer J Urol 147 1992 917 921
30. A.E. Katz G.M. deVries M.D. Begg Enhanced reverse transcriptase-polymerase chain reaction for prostate specific antigen as an indicator of true pathologic stage in patients with prostate cancer Cancer 75 1995 1642 1648
31. V.J. Kiesling J.W. McAnninch J.L. Goebel External beam radiotherapy for adenocarcinoma of the prostate: A clinical followup J Urol 124 1980 851 854
32. 1 prostate cancer. Cancer Res 45: 886-891, 198-5
33. D.A. Kuban A.M. El-Mahdi P. Schellhammer The significant of prostate biopsy with long-term follow-up Int J Radiat Oncol Biol Phys 24 1992 409 414
34. D.A. Kuban A.M. El-Mahdi P.F. Schelhammer Prognosis in patients with local recurrence after definitive irradiation for prostatic carcinoma Cancer 63 1989 2421 2425
35. K.H. Kurth J.E. Altwein D. Skoluda Followup of irradiated prostate carcinoma by aspiration biopsy J Urol 117 1972 615 617
36. C. Landmann R. Hunig Prostate specific antigen as an indicator of response to radiotherapy in prostate cancer Int J Radiat Oncol Biol Phys 17 1989 1073 1076
37. P.H. Lange D.J. Lightner E. Medini The effect of radiation therapy after radical prostatectomy in patients with elevated prostate specific antigen levels J Urol 144 1990 927 933
38. R.W. Lee G.E. Hanks B.W. Corn Observations of pretreatment antigen doubling time in 107 patients referred for definitive radiotherapy Int J Radiat Oncol Biol Phys 31 1995 21 24
39. P. Link F.S. Freiha T.A. Stamey Adjuvant radiation therapy in patients with detectable prostate specific antigen following radical prostatectomy J Urol 145 1991 532 534
40. D.R. Mador R.P. Huben W. Zev Salvage surgery following radical radiotherapy for adenocarcinoma of the prostate J Urol 133 1985 58 60
41. J.F. McCarthy W.J. Catalona M.A. Hudson Effect of radiation therapy on detectable serum prostate specific antigen levels following radical Early versus delayed treatment J Urol 151 1994 1575 1578
42. J.W. Moul D.F. Paulson The role of radical surgery in the management of radiation recurrent and large volume prostate cancer Cancer 68 1991 1265 1271
43. National Institutes of Health, National Cancer Institute SEER Cancer Statistics Review, 1973-1991. Publication No. 94-2789 1992 US Dept Health and Human Services, Public Health Service Bethesda, MD 374
44. O.S. Nielsen A.J. Munro I.F. Tannock Bone metastases: and management policy J Clin Oncol 9 1991 509 524
45. A.W. Partin R.N. Borland J.I. Epstein Influence of wide excision of the neurovascular bundles on prognosis; in men with clinically localized prostate cancer with established capsular penetration J Urol 150 1993 142 148
46. D.F. Paulson J.W. Moul P.J. Walther Radical prostatectomy for clinical stage T1-2N0M0 prostatic adenocarcinoma: Long-term results J Urol 144 1990 1180 1184
47. A. Pollack G.K. Zagars V.S. Kavadi Prostate specific antigen doubling time and disease relapse after radiotherapy for prostate cancer Cancer 74 1994 670 678
48. B.R. Prestige I. Kaplan R.S. Cox The clinical significance of a positive postirradiation prostatic biopsy without metastases Int J Radiat Oncol Biol Phys 24 1992 403 408
49. M.A. Ritter E.M. Messing T.G. Shanahan Prostate-specific antigen as a predictor of radiotherapy response and patterns of failure in localized prostate cancer J Clin Oncol 10 1992 1208 1217
50. K.J. Russell C. Dunatov M.D. Hafermann Prostate specific antigen in the management of patients with localized adenocarcinoma of the prostate treated with primary radiation therapy J Urol 146 1991 1046 1052
51. P.T. Scardino The prognostic significance of biopsies after radiotherapy for prostatic cancer Semin Urol 1 1983 243 251
52. P.T. Scardino T.M. Wheeler Local control of prostate cancer with radiotherapy: Frequency and prognostic significance of positive results of postirradiation prostate biopsy NCI Monogr 7 1988 95 103
53. P.T. Scardino J.M. Frankel T.M. Wheeler The prognostic significance of postirradiation biopsy results in patients with prostatic cancer J Urol 135 1986 510 515
54. 125 Iodine implant or external beam radiation therapy J Urol 137 1987 897 901
55. R.A. Sewell V. Braren S.K. Wilson Extended biopsy followup after full course radiation for respectable prostate carcinoma J Urol 13 1975 371 373
56. B.E. Shevlin B.B. Mittal W.N. Brand The role of adjuvant irradiation following primary prostatectomy, based on histopathologic extent of tumor Int J Radiat Oncol Biol Phys 16 1989 1425 1450
57. Smith A: Editorial comments. Proceedings of the 74th Annual Meeting, South Central Section, American Urological Association, Kansas City, MO, Sept 12, 1995
58. R.F. Smith S.M. Smith M.S. Austenfeld Outcomes of patients with biochemical (PSA) failure following prostatectomy J Urol 151 1994 257A
59. M.S. Soloway R. Sharifi Z. Wajsman Randomized prospective study comparing radical prostatectomy alone versus radical prostatectomy preceded by androgen blockade in clinical stage B2 (T2bNxM0) prostate cancer J Urol 154 1995 424 428
60. I. Thompson E.D. Crawford G. Miller Adjuvant radiotherapy following radical prostatectomy for pathologic stage C adenocarcinoma of the prostate: Initial evaluation of toxicity Proc Annu Meeting Am Soc Clin Oncol 11 1992 212
61. I.M. Thompson J.B. Rounder C.R. Spence Salvage radical prostatectomy for adenocarcinoma of the prostate Cancer 61 1988 1464 1466
62. M.K. Tibbs A.L. Zietman K.C. Dallow outcome following external beam radiation therapy for T1-2 prostate carcinoma: The importance of achieving an undetectable nadir PSA [abstract] Int J Radiat Oncol Biol Phys 32 suppl 1 1995 1016
63. J.G. Trapasso J.B. deKernion R.B. Smith The incidence and significance of detectable levels of serum prostate specific antigen after radical prostatectomy J Urol 152 1994 1821 1825
64. 125 Iodine reimplantation for locally progressive prostatic carcinoma J Urol 144 1990 704 706
65. G.K. Zagars A.C. von Eschenbach A.G. Ayala The influence of local control on metastatic dissemination of prostate cancer treatment by external beam megavoltage radiation therapy Cancer 68 1991 2370 2377
66. G.K. Zagars A. Pollack A.C. von Eschenbach Prostate cancer and radiation therapy—the message conveyed by serum prostate-specific antigen Int J Radiat Oncol Biol Phys 33 1995 23 35
67. G.K. Zagars N.E. Sherman R.J. Babaian Prostate specific antigen and external beam radiotherapy in prostate cancer Cancer 67 1991 412 420
68. A.L. Zietman J.J. Coen W.U. Shipley Radical radiation therapy in the management of prostatic adenocarcinoma: The initial prostate specific antigen value as a predictor of treatment outcome J Urol 151 1994 640 645